- Xeris Pharmaceuticals ( NASDAQ: XERS ) is scheduled to announce Q2 earnings results on Wednesday, August 10th, before market open.
- The consensus EPS Estimate is -$0.22 (-4.8% Y/Y) and the consensus Revenue Estimate is $25.53M (+155.3% Y/Y).
- Over the last 2 years, XERS has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 2 upward revisions and 1 downward.
For further details see:
Xeris Pharmaceuticals Q2 2022 Earnings Preview